Cita APA

Kudo, M., Galle, P. R., Llovet i Bayer, J. M., Finn, R. S., Vogel, A., Motomura, K., . . . Zhu, A. X. (2020). Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.

Citación estilo Chicago

Kudo, Masatoshi, et al. Ramucirumab in Elderly Patients With Hepatocellular Carcinoma and Elevated Alpha-fetoprotein After Sorafenib in REACH and REACH-2. 2020.

Cita MLA

Kudo, Masatoshi, et al. Ramucirumab in Elderly Patients With Hepatocellular Carcinoma and Elevated Alpha-fetoprotein After Sorafenib in REACH and REACH-2. 2020.